In contrast, here we discovered that the RNA edited sites of A3B had a higher incidence of coding region mutations, suggesting A3B activity could be a significant source of amino acid alterations contributing to tumour adaptation and drug resistance [47, 48]. This evidence concerns the gene APOBEC3B and neoplasm.